Involvement of the NF-κB pathway in multidrug resistance induced by HBx in a hepatoma cell line

Journal of Viral Hepatitis

Volumn 18, Issue 10, 2011, Pages

  Liu, Y ^a   Lou, G ^a   Wu, W ^a   Zheng, M ^a   Shi, Y ^a   Zhao, D ^a   Chen, Z ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

HBx; HCC cell line; multidrug resistance; NF B

Indexed keywords

DOXORUBICIN; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOSOME; SYNAPTOTAGMIN I;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HBV X GENE; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; UPREGULATION; VIRUS GENE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; FLUOROURACIL; GENE EXPRESSION PROFILING; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; NF-KAPPA B; TRANS-ACTIVATORS; TRANSFECTION;

EID: 80052833369     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01463.x     Document Type: Article

References (30)

1. Zuckerman AJ,. More than third of world's population has been infected with hepatitis B virus. BMJ 1999; 318: 1213. (Pubitemid 29201588)
2. Koike K, Tsutsumi T, Fujie H, Shintani Y, Kyoji M,. Molecular mechanism of viral hepatocarcinogenesis. Oncology 2002; 62 (Suppl. 1): 29-37. (Pubitemid 34702017)
3. Wang Y, Cui F, Lv Y, et al. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology 2004; 39: 318-324. (Pubitemid 38222172)
4. Jung EY, Kang HK, Chang J, Yu DY, Jang KL,. Cooperative transformation of murine fibroblast NIH3T3 cells by hepatitis C virus core protein and hepatitis B virus X protein. Virus Res 2003; 94: 79-84. (Pubitemid 36930031)
5. Cheng AS, Yu J, Lai PB, Chan HL, Sung JJ,. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis. Biochem Biophys Res Commun 2008; 374 (2): 175-180.
6. Yun C, Um HR, Jin YH, et al. NF-κB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. Cancer Lett 2002; 184: 97-104. (Pubitemid 34718111)
7. Kim SY, Kim JC, Kim JK, et al. Hepatitis B virus X protein enhances NFkappaB activity through cooperating with VBP1. BMB Rep 2008; 41 (2): 158-163.
8. Chung TW, Lee YC, Kim CH,. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J 2004; 18 (10): 1123-1125.
9. Diao J, Khine AA, Sarangi F, et al. X protein of hepatitis B virus inhibits as-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J Biol Chem 2001; 276: 8328-8340.
10. Ghosh S, Karin M,. Missing pieces in the NF-κB puzzle. Cell 2002; 109 (Suppl.): S81-S96.
11. Silverman N, Maniatis T,. NF-kB signaling pathways in mammalian and insect innate immunity. Genes Dev 2001; 15: 2321-2342. (Pubitemid 32899738)
12. Baeuerle PA, Baltimore D,. NF-kappa B: ten years after. Cell 1996; 87: 13-20.
13. Bonizzi G, Karin M,. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25: 280-288. (Pubitemid 38610351)
14. Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461-466. (Pubitemid 39329586)
15. Greten FR, Eckmann L, Greten TF, et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-296. (Pubitemid 39061110)
16. Arlt A, Gehrz A, Muerkoster S, et al. Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 2003; 22: 3243-3251. (Pubitemid 36712936)
17. Fojo T, Bates S,. Strategies for reversing drug resistance. Oncogene 2003; 22: 7512-7523. (Pubitemid 37487173)
18. Huang CC, Wu MC, Xu GW, et al. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma. J Natl Cancer Inst 1992; 84: 262-264.
19. Chou YY, Cheng AL, Hsu HC,. Expression of P-glycoprotein and p53 in advanced epatocellular carcinoma treated by single agent chemotherapy: clinical correlation. J Gastroenterol Hepatol 1997; 12: 569-575.
20. Fulda S, Debatin KM,. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006; 25: 4798-4811. (Pubitemid 44187627)
21. Ng SSW, Tsao MS, Chow S, Hedley DW,. Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Res 2000; 60: 5451-5455.
22. García MG, Alaniz LD, Cordo Russo RI, Alvarez E, Hajos SE,. PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines. Leuk Res 2009; 33 (2): 288-296.
23. Block TM, Mehta AS, Fimmel CJ, Jordan R,. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003; 22: 5093-5107. (Pubitemid 37059591)
24. Chung C, Park SG, Park YM, Joh JW, Jung G,. Interferon-gamma sensitizes hepatitis B virus-expressing hepatocarcinoma cells to 5-fluorouracil through inhibition of hepatitis B virus-mediated nuclear factor-kappaB activation. Cancer Sci 2007; 98 (11): 1758-1766. (Pubitemid 47487913)
25. Choi BH, Kim CG, Lim Y, Shin SY, Lee YH,. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett 2008; 259 (1): 111-118. (Pubitemid 350235095)
26. Mabuchi S, Ohmichi M, Nishio Y, et al. Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem 2004; 279: 23477-23485. (Pubitemid 38685659)
27. Wang W, Cassidy J, O'Brien V, Ryan KM, Collie-Duguid E,. Mechanistic and predictive profiling of 5-fluorouracil resistance in human cancer cells. Cancer Res 2004; 64: 8167-8176. (Pubitemid 39491752)
28. Huesker M, Folmer Y, Schneider M, Fulda C, Blum HE, Hafkemeyer P,. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes. Hepatology 2002; 36 (4 Pt 1): 874-884.
29. Bentires-Alj M, Barbu V, Fillet M, et al. NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 2003; 22 (1): 90-97. (Pubitemid 36152887)
30. Kucharczak J, Simmons MJ, Fan Y, Gelinas C,. To be, or not to be. NF-κB is the answer role of Rel/NF-κB in the regulation of apoptosis. Oncogene 2003; 22: 8961-8982. (Pubitemid 38121698)